Safety and Efficacy Evaluation of Pleconaril for Treatment of the Common Cold | Zendy

F.E. Russell | Zendy; Katherine Laessig | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Efficacy Evaluation of Pleconaril for Treatment of the Common Cold

Author(s) -

F.E. Russell,

Katherine Laessig

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/379830

Subject(s) - medicine , common cold , intensive care medicine , immunology

losis under routine conditions with additional information on side effects and contact tracing. Tuber Lung Dis 1996; 77:425–8. 7. Gonzalez-Montaner LJ, Natal S, Yongchaiyud P, et al. Rifabutin for the treatment of newlydiagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicin. Rifabutin Study Group. Tuber Lung Dis 1994; 75:341–7. 8. Castelo A, Jardim JR, Goihman S, et al. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Lancet 1989; 2: 1173–6. 9. Glynn JR, Warndorff DK, Fine PE, et al. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Bull World Health Organ 1998; 76:295–305. 10. Harries AD, Chimzizi RB, Nyirenda TE, et al. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes? Int J Tuberc Lung Dis 2003; 7: 616–22.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research